Technical Specialist, Newcastle University

```html

Review: Therapeutic Innovation Newcastle Drug Discovery Group - Protein Expression & Purification Specialist

This opportunity within the Cancer Research Horizons Therapeutic Innovation Newcastle Drug Discovery Group at Newcastle University presents a compelling prospect for individuals passionate about contributing to cutting-edge cancer research. As a member of a multidisciplinary team, you'll be instrumental in identifying novel therapeutic approaches, working alongside experienced biologists, structural biologists, and chemists.

Key Advantages for Candidates:

• Impactful Research: Engage in meaningful work aimed at discovering new treatments for cancer, directly contributing to a significant global health challenge.
• Collaborative Environment: Become part of a dynamic, interdisciplinary team, fostering a rich learning environment and opportunities for professional growth through diverse perspectives.
• Skill Development: The role offers extensive opportunities to hone and expand your expertise in crucial areas such as protein expression, purification, characterisation, crystallisation, and structure determination. You'll be involved in developing new protocols and optimising experimental systems.
• Career Progression: The advertised salary range includes progression opportunities, indicating a commitment to rewarding your development and contributions.
• Excellent Employee Benefits: Newcastle University is recognised for its attractive benefits package, including a generous holiday allowance (with the option to purchase more), competitive pension schemes, and comprehensive health and wellbeing initiatives. This demonstrates a strong commitment to employee welfare.
• Reputable Institution: Working at Newcastle University, a global institution with a strong commitment to equality, diversity, and inclusion, offers a stable and supportive working environment. Their achievements with the Athena Swan award and Race Equality Charter further underscore their dedication to a positive workplace culture.

Key Considerations for Candidates:

• Fixed-Term Contract: The positions are funded by Cancer Research UK on a fixed-term basis until October 2027. Candidates should be aware of this duration when considering their career trajectory.
• Technical Specialisation: While the role offers deep technical development, it requires a strong foundation and demonstrable experience in molecular biology, protein expression, purification, and characterisation. Candidates should assess their current skill set against the requirements outlined in the job description.
• Independent Working & Problem Solving: The role demands a high degree of autonomy, requiring you to resolve most challenges without constant supervision. Flexibility, reliability, and the ability to work independently are paramount.
• Health and Safety Focus: A thorough understanding and consistent application of Health and Safety procedures are critical. You will be expected to hold specific safety responsibilities and ensure compliance.
• Reporting Structure: You will report to multiple academic leads and the Institute Technical Manager, requiring effective communication and collaboration across different levels of the organisation.
• Medical Clearance: Be prepared for a medical clearance process prior to commencing employment in this role.

Guidance for Career Path:

This role is an excellent stepping stone for individuals seeking to specialise and excel in the field of structural biology and drug discovery. The opportunity to develop advanced technical skills, contribute to significant research projects, and work within a leading academic institution will be invaluable. For those aspiring to senior technical roles, research leadership, or further academic pursuits, the experience gained here will provide a robust foundation. Candidates with a strong desire to contribute to medical advancements and who thrive in a research-intensive, collaborative setting will find this position particularly rewarding.

Note: The closing date for applications is 30 January 2026.